Skip to results
Modify your search
NARROW
1-7 of 7
Authors: Carmen Belli
Journal Article
Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers
The Oncologist, Volume 29, Issue 8, August 2024, Pages 707–715, https://doi.org/10.1093/oncolo/oyae125
Published: 01 June 2024
Journal Article
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis
The Oncologist, Volume 29, Issue 7, July 2024, Pages 560–565, https://doi.org/10.1093/oncolo/oyae082
Published: 08 May 2024
Journal Article
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology
The Oncologist, Volume 29, Issue 6, June 2024, Pages 504–510, https://doi.org/10.1093/oncolo/oyae038
Published: 23 March 2024
Journal Article
Immune-Related Adverse Event Likelihood Score Identifies “Pure” IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population
The Oncologist, Volume 29, Issue 2, February 2024, Pages e266–e274, https://doi.org/10.1093/oncolo/oyad239
Published: 16 September 2023
Journal Article
Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience
The Oncologist, Volume 29, Issue 2, February 2024, Pages 159–165, https://doi.org/10.1093/oncolo/oyad229
Published: 05 September 2023
Journal Article
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents
The Oncologist, Volume 29, Issue 1, January 2024, Pages 75–83, https://doi.org/10.1093/oncolo/oyad212
Published: 07 August 2023
Journal Article
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability‐High End‐Stage Cancers and Poor Performance Status Related to High Disease Burden
The Oncologist, Volume 25, Issue 9, September 2020, Pages 803–809, https://doi.org/10.1634/theoncologist.2020-0014
Published: 20 May 2020
